by Elena Iemma | Sep 22, 2023
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Rare Diseases
by Elena Iemma | Sep 22, 2023
iVAX for antigen discovery, vaccine design, diagnostics, and epidemiology
by Elena Iemma | Sep 22, 2023
Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics… of Peptides and P-ANDAS
by Elena Iemma | Sep 21, 2023
In silico immunogenicity risk assessment for fusion proteins and novel antibody modalities
by Corey Iacono | Nov 17, 2022
EpiVaxTx_SITC22_Melanoma_28Oct22_56Wx31.5H